News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Aspen Pharmacare Holdings Said to Reduce Its $589 Million Takeover Offer for Sigma Pharmaceuticals
July 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
July 6 (Bloomberg) -- Aspen Pharmacare Holdings Ltd. will reduce its A$707 million ($589 million) takeover offer for Sigma Pharmaceuticals Ltd. after reviewing the Australian company’s accounts, a person familiar with the matter said.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Africa
MORE ON THIS TOPIC
Mergers & acquisitions
UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along
May 4, 2026
·
2 min read
·
Tristan Manalac
Earnings
Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks
April 30, 2026
·
5 min read
·
Gabrielle Masson
Insights
What makes life science angel investment work?
April 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Earnings
With growth curve trending up, Biogen looks to early-stage assets for ‘next generation’
April 29, 2026
·
3 min read
·
Annalee Armstrong